The NK-1 receptor: a new target in cancer therapy

M Munoz, M Rosso, R Covenas - Current drug targets, 2011 - ingentaconnect.com
After binding to the specific neurokinin-1 (NK-1) receptor, the peptide substance P (SP),
which is widely distributed in both the central and peripheral nervous systems, induces …

Gap junction–mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells

PK Lim, SA Bliss, SA Patel, M Taborga, MA Dave… - Cancer research, 2011 - AACR
Bone marrow (BM) metastasis of breast cancer (BC) can recur even decades after initial
diagnosis and treatment, implying the long-term survival of disseminated cancer cells in a …

Reporters of cancer stem cells as a tool for drug discovery

A Mohan, R Raj R, G Mohan, P KP… - Frontiers in …, 2021 - frontiersin.org
In view of the importance of cancer stem cells (CSCs) in chemoresistance, metastasis and
recurrence, the biology of CSCs were explored in detail. Based on that, several modalities …

[HTML][HTML] Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers

G Grisendi, R Bussolari, E Veronesi… - American Journal of …, 2011 - ncbi.nlm.nih.gov
A tumor represents a complex structure containing malignant cells strictly coupled with a
large variety of surrounding cells constituting the tumor stroma (TS). In recent years, the …

Tumor microenvironment and breast cancer progression: a complex scenario

A Artacho-Cordón, F Artacho-Cordón… - Cancer biology & …, 2012 - Taylor & Francis
It is now widely accepted that the development and progression of a tumor toward the
malignant phenotype is highly dependent on interactions between tumor cells and the tumor …

Exosomes as a nano-carrier for Chemotherapeutics: a new era of oncology

RP Araldi, DA Delvalle, VR da Costa, AL Alievi… - Cells, 2023 - mdpi.com
Despite the considerable advancements in oncology, cancer remains one of the leading
causes of death worldwide. Drug resistance mechanisms acquired by cancer cells and …

3D Modular Bioceramic Scaffolds for the Investigation of the Interaction between Osteosarcoma Cells and MSCs

J Hao, X Yu, K Tang, X Ma, H Lu, C Wu - Acta Biomaterialia, 2024 - Elsevier
Recent advances in bone tissue engineering have shown promise for bone repair post
osteosarcoma excision. However, conflicting research on mesenchymal stem cells (MSCs) …

[HTML][HTML] AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells

SJ Greco, SA Patel, M Bryan, LF Pliner… - American Journal of …, 2011 - ncbi.nlm.nih.gov
Breast cancer cells (BCCs) can remain quiescent for a long period, before detection and
during remission. Mesenchymal stem cells (MSCs) exert both protective and growth support …

Mesenchymal stromal cells; role in tissue repair, drug discovery and immune modulation

K English, BP Mahon, KJ Wood - Current drug delivery, 2014 - ingentaconnect.com
Mesenchymal stromal cells (MSCs) participate in repair of damaged tissues, possess the
potential to serve as a useful tool in the drug discovery field and exert immunosuppressive …

IL-6 originated from breast cancer tissue-derived mesenchymal stromal cells may contribute to carcinogenesis

Ö Sağlam, ZS Ünal, C Subaşı, E Ulukaya, E Karaöz - Tumor Biology, 2015 - Springer
Tumor microenvironment is an important factor, which sustains and promotes the tumors by
inflammatory signals. Interleukin-6 (IL-6) is known as a multifunctional cytokine, which is a …